Cargando…

Low-grade metabolic acidosis as a driver of insulin resistance

Detalles Bibliográficos
Autores principales:	DiNicolantonio, James J, O'Keefe, James H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438953/ https://www.ncbi.nlm.nih.gov/pubmed/34497064 http://dx.doi.org/10.1136/openhrt-2021-001788

Ejemplares similares

Low-grade metabolic acidosis as a driver of chronic disease: a 21st century public health crisis
por: DiNicolantonio, James J, et al.
Publicado: (2021)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Importance of maintaining a low omega–6/omega–3 ratio for reducing inflammation
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Added sugars drive coronary heart disease via insulin resistance and hyperinsulinaemia: a new paradigm
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Markedly increased intake of refined carbohydrates and sugar is associated with the rise of coronary heart disease and diabetes among the Alaskan Inuit
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis
por: DiNicolantonio, James J, et al.
Publicado: (2018)

The introduction of refined carbohydrates in the Alaskan Inland Inuit diet may have led to an increase in dental caries, hypertension and atherosclerosis
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Effects of dietary fats on blood lipids: a review of direct comparison trials
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance
por: DiNicolantonio, James J, et al.
Publicado: (2019)

Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Magnesium for the prevention and treatment of cardiovascular disease
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Importance of maintaining a low omega-6/omega-3 ratio for reducing platelet aggregation, coagulation and thrombosis
por: DiNicolantonio, James J, et al.
Publicado: (2019)

Lorcaserin for the treatment of obesity? A closer look at its side effects
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Decreased magnesium status may mediate the increased cardiovascular risk associated with calcium supplementation
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Role of dietary histidine in the prevention of obesity and metabolic syndrome
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome
por: DiNicolantonio, James J, et al.
Publicado: (2019)

Does elevated bilirubin aid weight control by preventing development of hypothalamic leptin resistance?
por: DiNicolantonio, James J, et al.
Publicado: (2019)

Dietary fats, blood pressure and artery health
por: DiNicolantonio, James J, et al.
Publicado: (2019)

The benefits of marine omega-3s for preventing arrhythmias
por: DiNicolantonio, James J, et al.
Publicado: (2020)

Perindopril for improving cardiovascular events
por: DiNicolantonio, James J, et al.
Publicado: (2014)

The Importance of Marine Omega-3s for Brain Development and the Prevention and Treatment of Behavior, Mood, and Other Brain Disorders
por: DiNicolantonio, James J., et al.
Publicado: (2020)

Capsaicin may have important potential for promoting vascular and metabolic health
por: McCarty, Mark F, et al.
Publicado: (2015)

Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
por: DiNicolantonio, James J, et al.
Publicado: (2015)

The health benefits of vitamin K
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Copper deficiency may be a leading cause of ischaemic heart disease
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Effects of spirulina on weight loss and blood lipids: a review
por: DiNicolantonio, James J, et al.
Publicado: (2020)

Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Pentoxifylline for vascular health: a brief review of the literature
por: McCarty, Mark F, et al.
Publicado: (2016)

Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Nutraceutical Prevention of Diabetic Complications—Focus on Dicarbonyl and Oxidative Stress
por: McCarty, Mark F., et al.
Publicado: (2022)

Nutraceutical activation of Sirt1: a review
por: DiNicolantonio, James J, et al.
Publicado: (2022)

A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis
por: DiNicolantonio, James J, et al.
Publicado: (2021)

Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes
por: Fares, Hassan, et al.
Publicado: (2016)

The cardiometabolic consequences of replacing saturated fats with carbohydrates or Ω-6 polyunsaturated fats: Do the dietary guidelines have it wrong?
por: DiNicolantonio, James J
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cempt49kafb08ihibe59hj88c8